Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk.

Regular coffee consumption (2-3 cups/day) protects against liver cirrhosis, reduces fibrosis, prevents liver cancer, and ...

This article explores compensated cirrhosis in more detail, including its causes, diagnosis, and treatment. It also answers some common questions about the condition. Healthcare professionals ...

LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...

Sarcopenia is a common complication of decompensated cirrhosis resulting in progressive loss of muscle mass and function. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Untreated, PBC can lead to cirrhosis, liver failure ... was hampered by unblinding and treatment crossover but nonetheless failed to demonstrate a significant benefit in the full study population ...

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

the company's drug candidate for the treatment for sarcopenia, a progressive loss of muscle mass and function, in patients with decompensated cirrhosis. According to National Institutes of Health ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that ...